Research on experimental hyperlipemia. II. Isolation and "in vitro" study of a natural inhibitor of the clarifying factor
Tayeau, F.; Jouzier, E.; Tixier, M.
Bordeaux Medical 3(9): 1999-2008
1970
ISSN/ISBN: 0021-7867 PMID: 5481183 Document Number: 19232
Document emailed within 1 workday
Related Documents
Tayeau, F.; Jouzier, E.; Tixier, M. 1970: Research on experimental hyperlipemia. 3. Action "in vivo" of the inhibitor of the clarifying factor Bordeaux Medical 3(9): 2011-2014Kumari, N.N.; Pattabiraman, T.N. 1990: Natural plant enzyme inhibitors: isolation and properties of a trypsin inhibitor from jack bean (Canavalia ensiformis) Indian Journal of Biochemistry and Biophysics 27(5): 332-338
Huang, C.-y.; Shen, Z.-y. 2002: Vascular endothelial growth factor--fundamental research and experimental study in plastic surgery Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 16(1): 64-69
Sun, S.; Gao, Q.; Zhang, G.; Tan, Y. 2015: Experimental study on the effects of the nerve growth factor regulating calcitonin gene-related peptide in promoting the proliferation of MG-63 in vitro Hua Xi Kou Qiang Yi Xue Za Zhi 33(3): 234-237
Carreras, L.O.; Perez, G.N.; Xavier, D.L.; Blanco, A.N.; Penalva, L.B. 1988: Autoimmune factor VIIi inhibitor responsive to gammaglobulin without in vitro neutralisation Thrombosis and Haemostasis 60(2): 343
Nagase, H.; Enjyoji, K.; Kamikubo, Y.; Kitazato, K.T.; Kitazato, K.; Saito, H.; Kato, H. 1997: Effect of depolymerized holothurian glycosaminoglycan (DHG) on tissue factor pathway inhibitor: in vitro and in vivo studies Thrombosis and Haemostasis 78(2): 864-870
Ray, S 1997: Prevention of HIV/STI transmission: clarifying the research questions Reproductive Health Matters 5(10): 154-155
Błach-Olszewska, Z.; Wrześniowska, U. 1986: Inhibitor of physiological interferon synthesis. I. Isolation, physiochemical and biological properties of crude inhibitor preparations Archivum Immunologiae et Therapiae Experimentalis 34(5-6): 533-540
Messer, M. 2016: Clarifying the goals of the research and selecting information sources Pflege Zeitschrift 69(5): 300
Holst, J.; Lindblad, B.; Matthíasson, S.E.; Stjernquist, U.; Ezban, M.; Ostergaard, P.B.; Hedner, U. 1996: Experimental haemorrhagic effect of two-domain non-glycosylated tissue factor pathway inhibitor compared to low molecular weight heparin Thrombosis and Haemostasis 75(4): 585-589
Tarter, T.H.; Cunningham-Rundles, S.; Koide, S.S. 1986: Suppression of natural killer cell activity by human seminal plasma in vitro: identification of 19-OH-PGE as the suppressor factor Journal of Immunology 136(8): 2862-2867
Takeuchi, N. 1972: Experimental hyperlipemia Nihon Rinsho. Japanese Journal of Clinical Medicine 30(1): 347-350
Yamazaki, M.; Asakura, H.; Aoshima, K.; Saito, M.; Jokaji, H.; Uotani, C.; Kumabashiri, I.; Morishita, E.; Ikeda, T.; Matsuda, T. 1994: Effects of DX-9065a, an orally active, newly synthesized and specific inhibitor of factor Xa, against experimental disseminated intravascular coagulation in rats Thrombosis and Haemostasis 72(3): 392-396
Rao, C.; Liu, X.; Zhang, P.L.; Chen, W.M.; Fang, Q.C. 1991: Application of high speed countercurrent chromatography for the isolation of natural products--preparative isolation of taxane-diterpenoids and diterpene alkaloids Yao Xue Xue Bao 26(7): 510-514
Gries, F.A. 1975: Risk factor hyperlipemia: clinical aspects and therapy Die Medizinische Welt 26(36): 1590-1597
Hashimoto, T.; Kobayashi, M.; Igarashi, H.; Niitani, H. 1975: Hyperlipemia as a risk factor in ischemic heart disease Nihon Rinsho. Japanese Journal of Clinical Medicine 33(11): 3179-3184
Picardi, N.; Grassetti, U.; Forte, A.; Pasta, V.; Monti, M.; D'Andrea, G.; Agosta, F.; Menis, C.; Rosati, R.; Vietri, F. 1981: Experimental method for research on the zero hemodynamic level in the major circulation for the experimental study of venous pressures Annali Italiani di Chirurgia 53(3): 321-328
Dzirlo-Todorović, J. 1996: Culture of endothelial cells as an in vitro model for experimental and clinical research Medicinski Arhiv 50(3-4): 73-76
Rémy, A.; Avouac, J.; Gossec, L.; Combe, B. 2011: Clinical relevance of switching to a second tumour necrosis factor-alpha inhibitor after discontinuation of a first tumour necrosis factor-alpha inhibitor in rheumatoid arthritis: a systematic literature review and meta-analysis Clinical and Experimental Rheumatology 29(1): 96-103
Florholmen, J.; Burhol, P.G.; Vonen, B. 1985: Islands of Langerhans. Isolation, in vitro study and transplantation Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 105(32): 2302-2306